The EU-Canada Comprehensive Economic and Trade Agreement (CETA) Opening up a wealth of opportunities for people in Sweden

CETA will benefit people across Sweden It'll do so by: Scrapping customs tariffs for Swedish exporters and importers Opening up the Canadian services market to Swedish firms Enabling Swedish firms to bid for more public contracts in Canada Protecting Sweden's research and creativity Making it easier for Swedish professionals to work in Canada Encouraging more investment between Sweden and Canada Helping Sweden's small businesses export more to Canada

1 European Commission, February 2017 ec.europa.eu/ceta @Trade_EU

Sweden's economy is open to trade Over 763,000 Swedish jobs – one in five – rely on exports outside Europe And Sweden and Canada already have a close trading and investment relationship

11th When it comes to goods, Canada is Sweden's 11th biggest trade partner outside the EU

€300 m The value of Sweden's trade surplus in goods and services with Canada

€1.3 bn The value of Swedish exports to Canada

€1 bn The value of Swedish imports from Canada

2 2

Scrapping customs tariffs on Swedish exports of goods Swedish goods exports to Canada: €977 m (2015)

 Pharmaceuticals

CETA will bring big savings on customs duties by eliminating duties on 99% of all tariff lines, of which 98% will already be scrapped at entry into force.

Swedish exports to Canada: €215 m (2015)

Sweden will benefit from tariffs being removed on virtually all of its exports, in particular:

The pharmaceutical industry faces very low tariffs but will particularly benefit from CETA's intellectual property provisions (see below).

 Machinery and electrical equipment

Swedish exports to Canada: €330 m (2015) These sectors employ 90,000 people in Sweden. Machinery and electrical equipment face low average tariffs but some products face tariff peaks of 9%.

This sector employs 30,000 people in Sweden.

The protocol on mutual recognition of Good Manufacturing Practices (GMP) will make it easier to trade in this sector, by allowing one party's authorities to accept GMP compliance certificates issued by the other party.  Motor vehicles and parts

Swedish exports to Canada: €80 m (2015) Apart from savings on customs duties, CETA will enable Swedish companies to do away with costs of double testing thanks to the provisions on recognition of conformity assessment certificates in sectors such as:  machinery  electrical goods  electronic equipment

Sweden is the EU’s 5th largest exporter of motor vehicles to Canada. This sector employs around 80,000 people in Sweden. Canadian tariffs are up to 9.5%.  Optical instruments and medical

instruments These sectors will also benefit from CETA's provisions on public procurement and movement of professionals (see below).

Swedish exports to Canada: €27 m (2015) Canadian tariffs are up to 8.5%.

3 3

 Vodka

Swedish exports to Canada: €24 m (2015)

Regarding wine and spirits CETA also:

Vodka faces specific duties of 12.28 CAD cents per litre of pure alcohol. For wine and spirits, tariff elimination is complemented by the removal of other relevant trade barriers, including several 'behind the border' barriers that make it difficult for Swedish exporters to access the Canadian market.

 abolishes the Canadian requirement to blend imported bulk spirits with local spirits before bottling – a requirement that made it impossible for EU makers of products classified as Geographical Indications from labelling them as such.

The cost-of-service-differential fee imposed by the Provincial Liquor Boards on imported wines and spirits will for instance be:  applied based on volume and not value  calculated more transparently This lowers the costs for EU producers to sell their products in Canada. CETA will ensure that EU wine and spirit producers can compete on the Canadian market, for example by:

 incorporates the 2004 EU-Canada Wines and Spirits Agreement. Because this will be made subject to CETA's general rules, notably dispute settlement, the legal guarantees become stronger.  provides a forum for further discussions in the future on any other issue of concern for the EU and Canada related to Wines and Spirits. The EU expects that the combined effect of these measures will be to further increase the EU market share of the Canadian wine and spirit sector.

 freezing the number of shops selling only Canadian products, and  preventing businesses with a local monopoly from expanding into neighbouring provinces.

4 4

Opening up the Canadian services market to Swedish firms

Swedish services exports to Canada: €313 m (2015) Sweden's main services exports to Canada are:

For example in the professional services sector, Canada has removed a number of limitations on citizenship and residency conditions for Swedish professionals to practice in Canada, who are:

   

   

telecommunications transport tourism financial services

CETA will improve and secure Swedish companies’ access to the Canadian services market.

lawyers accountants architects engineers

CETA also brings legal certainty for EU services exporters: Canada has locked in its current level of openness towards EU companies, for example in:  financial services  telecoms  postal and courier services

Enabling Swedish firms to bid for more public contracts in Canada

With CETA, Swedish companies will get access to Canada's large public procurement market. Swedish companies will have the opportunity to bid to supply goods and services for tenders at all levels of government in Canada (federal, provincial and municipal).

Canada has also agreed to make the tendering process more transparent by publishing its federal and provincial public tenders on a single procurement website. Canada's government procurement commitments in CETA are the most ambitious Canada has ever granted.

5 5

Protecting Sweden's research and creativity

Swedish Gross Domestic Product percentage spent on research and development: 3.16% (2014) This is the 2nd highest proportion of all EU member states. CETA gives Swedish innovations, copyrights and trademarks a similar level of protection in Canada to that they enjoy in Europe. In particular, Canada will bring its copyright protection in line with international standards. This is important because it will protect the intellectual property of EU's creative industries (artworks, publications, music and software), including its dissemination through online distribution channels. CETA also covers intellectual property rights for pharmaceuticals. The agreement includes:  the possibility of up to two years of additional patent protection to compensate for undue delays in granting the marketing authorisation that reduce the useful life of the patent

a generic drug and the patent status of the originator drug)  a commitment to maintain Canada's current practice of offering eight years of data protection. This is good news for Sweden, given the importance of chemicals and pharmaceuticals in Sweden’s exports to Canada. CETA also provides a high level of protection for 143 distinctive EU food and drink products that hold a geographical indication (GI) – a sign to show they have a specific geographical origin and possess qualities or enjoy a reputation because of it. With CETA, Canadian producers won’t be able to sell local or foreign products as European GIs if they are not the real thing. So, for example, they won’t be able to market fish roe as Kalix Löjrom unless it comes from vendace fish from Kalix in Northern Sweden. The prioritised list of 143 distinctive products was chosen by EU Member States on the basis of their export potential to Canada.

 a commitment to ensure that all litigants have an effective right of appeal under Canada's patent linkage regime (the link between the marketing authorisation for

6 6

Making it easier for Swedish professionals to work in Canada

CETA includes provisions to make it easier for Swedish professionals to work in Canada (and vice versa) and to have their qualifications recognised. This is a big plus for companies that:  provide services such as after sales services for exported machines or information and communication technologies software  make complex products that require after sales services such as installation or maintenance of machinery.

CETA establishes legal certainty and significantly improves mobility for services suppliers because it:  makes it easier to transfer key personnel across the Atlantic  allows companies to send staff for after sales services for machinery, software and equipment  creates a framework for the recognition of professional qualifications for regulated sectors like architects and accountants.

Provisions to facilitate movement of people can be particularly beneficial for small and medium-sized firms, as they may not be able to provide permanent staff on the ground to directly supply the service.

7 7

Encouraging investment between Sweden and Canada

Swedish Foreign Direct Investment in Canada: €2.63 bn (2015)

Sweden does not have a bilateral investment treaty with Canada.

CETA will make it easier for Swedish firms to invest in Canada, as Canada has agreed to substantially increase the threshold for reviewing the acquisition of Canadian companies by non-Canadians from CAN $354 million (€247.26 million) to CAN $1.5 billion (€1.4 billion).

This makes the investment protection and the dispute settlement provisions in CETA all the more relevant to Swedish investors in Canada and Canadian investors in Sweden.

Canadian Foreign Direct Investment in Sweden: €1.81 bn (2008) Canada, for its part, has interests in Sweden in many fields. In 2012 for example the Canada Pension Plan Investment Board invested €122 million in the Kista Galleria, a mall north of Stockholm’s central business district.

Once CETA enters into force definitively, these provisions will provide Swedish and Canadian investors with greater predictability, transparency, and protection for their investments in Canada and in Sweden respectively.

8 8

Helping Sweden's small businesses export more to Canada

Swedish small businesses are very export oriented and make up 94% of the total number of Swedish exporters. They will be able to take full advantage of CETA. Reduced trade barriers, tariff elimination, simplified customs procedures and more compatible technical requirements all make it easier and cheaper to export.

Specific provisions reinforce the CETA benefits for small companies, such as:  taking into account their needs in electronic commerce  improved access to information on public procurement tenders  the use of the Investment Court System.

This allows smaller firms to:  compete more easily with large companies  sell the same product (or with fewer modifications) into both markets

The Investment Court System provisions in CETA allow for faster proceedings and reduced costs for smaller firms that bring a case.

 participate more in supply chains and ecommerce.

9 9

The CETA Agreement - European Commission - Europa EU

Regarding wine and spirits CETA also: • abolishes the Canadian requirement to blend imported bulk spirits with local spirits before bottling – a requirement that made it impossible for EU makers of products classified as Geographical. Indications from labelling them as such. • incorporates the 2004 EU-Canada. Wines and ...

474KB Sizes 0 Downloads 256 Views

Recommend Documents

EU ACC3 - European Commission - Europa EU
As a shipper, freight forwarder, screening facility, ground handler or postal operator you may handle cargo or mail relevant to this programme. Is your company.

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.